Objective: Oxidative stress has increasingly been implicated in the development and progression of many vascular diseases. Previous work from our laboratory indicated that peroxynitrite alters vasoactive pathways in endothelial cells, which could potentially reduce vascular relaxation. To test this hypothesis in vivo, we utilized an animal model of endogenous oxidative stress, the CuZn superoxide dismutase (SOD) knockout mouse, to assess vascular function. Methods: Vascular reactivity of mouse mesenteric arteries was assessed in the presence or absence of inhibitors to nitric oxide synthase (NOS) and/or prostaglandin H synthase (PGHS). Endothelial-dependent function was also measured after the addition of exogenous SOD. Peroxynitrite formation was detected by nitrotyrosine immunofluorescence in mesenteric arteries. Results: Our data indicate that endothelial-dependent relaxation responses to methacholine are highly reduced in SODÀ/À mice (P<0.01, ANOVA). In only the wild-type mice, NOS or PGHS inhibition significantly blunted relaxation, suggesting that vasodilators from these pathways are present only in the controls and not in SODÀ/À mice. A combination of NOS and PGHS inhibitors reduced methacholine relaxation in both wild-type and SODÀ/À mice. This residual EDHF-like relaxation was not different between groups. After incubation with exogenous SOD, endothelialdependent relaxation could be partially restored in SODÀ/À mice, due to increased NOS-mediated vasodilation. In addition, peroxynitrite formation was significantly elevated in mesenteric arteries from SODÀ/À mice. Conclusion: Our data suggest that in a novel animal model of oxidative stress, vessel function is compromised due to alterations in NOS and PGHS-dependent relaxation responses.
Introduction
Oxidative stress occurs when biological systems encounter either an excess of pro-oxidants and/or have reduced anti-oxidant capacity, and has been hypothesized to play a role in the pathophysiology of cardiovascular disease [1] . Superoxide anion is a key mediator in many of the deleterious actions of reactive oxygen species. The superoxide radical itself has been implicated in mediating vascular dysfunction [2] , but superoxide anion also initiates the formation of many reactive oxygen species. For example, superoxide anion is the precursor to hydrogen peroxide, which can be hydrolyzed into the potent hydroxyl radical, an initiator of lipid peroxidation. Further, superoxide anion scavenges nitric oxide, forming peroxynitrite, which occurs at a rate significantly more rapid than the reaction of superoxide with the enzyme superoxide dismutase (SOD) [3, 4] .
The reaction of superoxide with nitric oxide reduces the bioavailability of nitric oxide as a vasodilator. Additionally, peroxynitrite itself substantially impacts the vascular system. We previously found that peroxynitrite affects endothelial cells in culture by reducing protein levels of prostacyclin synthase, as well as by inducing nuclear translocation of the oxidant-sensitive transcription factor, NFn-B [5] . Other laboratories have found that peroxynitrite activates the enzyme upstream of prostacyclin synthase, prostaglandin H synthase (PGHS) which also produces the vasoconstrictor thrombox-ane, in addition to prostacyclin [6] . Overall, these alterations may shift the balance between dilators and constrictors, leading to a reduced capacity for vasorelaxation.
Pro-oxidants are typically maintained at low intracellular levels by both enzymatic and nonenzymatic mechanisms. Pertinent to our study, superoxide dismutase (SOD) is the enzyme responsible for converting the free radical superoxide anion into hydrogen peroxide, which is then neutralized by catalase into water [7] . SOD exists as three isoforms; SOD-1 is copper -zinc dependent and localized to the cytosol (CuZn SOD), SOD-2 is manganese dependent and found in the mitochondria (Mn SOD) and there is also an extracellular SOD (EC-SOD) [1] . The Mn SOD isoform plays a critical role in the protection from oxidants inside the mitochondria, which produces copious amounts during cellular respiration. Although homozygous knockout Mn SOD mice die within the first 10 days of life, [8] , the phenotype of the heterozygotes includes increased susceptibility to oxygen toxicity [9] as well as altered cardiac mitochondrial function and increased oxidative injury [10] . On the other hand, the cytosolic isoform, CuZn SOD scavenges superoxide that has been produced from enzymatic processes, such as NADPH oxidase [11] . Thus, the CuZn SOD À / À mouse constitutes a proficient model to assess the influence of elevated superoxide anion, in vivo, on vascular function.
Based on the importance of oxidative stress in the pathogenesis of vascular dysfunction, we sought to determine the effect of increased cytosolic superoxide radicals on blood vessel reactivity, focussing on endothelial cell vasoactive pathways that are altered by pro-oxidant molecules. We hypothesized that resistance-sized blood vessels from SOD À / À mice will have reduced endothelial-mediated relaxation and enhanced vasoconstriction, due to impaired PGHS and nitric oxide-dependent mechanisms.
Materials and methods

Animal housing and protocols
Heterozygous pair of B6, 129S-SOD1 mice were purchased from Jackson Laboratories (Bar Harbour, ME), and were subsequently bred at our facility. Mice were housed in a virus-antigen free environment, kept at 20% humidity, under 12 h light/dark cycles and fed standard laboratory chow and water ad libitum. Genotype was determined at the University of Alberta Transgenic Facility using specific primers for the mutated gene. Experimental groups consisted of wild type (control; females n = 6 and males n = 8) vs. homozygous knockout littermates (SOD À / À ; females n = 5 and males n = 7). Initial experiments considered males and females as separate groups, but after data analysis, we found that there was not a statistical difference, thus data from both groups were pooled. Mice were used between 5 and 7 months of age. All protocols used for this study were approved by the University of Alberta Health Sciences Animal Policy and Welfare Committee and were in accordance with the Canadian Council on Animal Care.
Vessel function
This study focuses on the characterization of vascular reactivity in mesenteric arteries, since they are small resistance sized arteries that contribute substantially to overall peripheral vascular resistance [12] . Mesenteric arcades were removed from the animal after cervical dislocation and placed immediately into ice-cold Dulbecco Modified Essential Medium (DMEM) buffer (1 mmol/l sodium pyruvate, 25 mmol/l sodium bicarbonate, 5 mmol/l HEPES, 5 mmol/ l D + glucose; pH 7.4) which was used to maintain vessel viability [13] . Second-order mesenteric arteries ( f 150 Am) were cleaned free of fat and connective tissue under a light microscope. After threading with two smooth 20 Am tungsten wires, vessels were mounted in an isometric wire myograph system (Kent Scientific, Litchfield, CT), warmed to 37 jC (bathed in 5 ml of DMEM buffer) and equilibrated for 30 min.
Myograph protocols
At the start of each experiment, vessel length was measured using a micrometer and a passive circumferencetension curve was performed for each vessel to determine the optimum resting tension. Cumulative dose response curves were initially performed for phenylephrine (1 -50 Amol/l). Vessels were used for subsequent relaxation curves if they attained a minimum of 1.0 mN/mm of tension in response to phenylephrine. Phenylephrine dose response curves were repeated after a 20 min pre-incubation with either N G -nitro-L-arginine methyl ester (L-NAME; 100 Amol/l; nitric oxide synthase (NOS) inhibitor) or meclofenamate (1.0 Amol/l, PGHS inhibitor). The concentration of phenylephrine required to produce an 80% response (EC 80 ) was used to pre-constrict the vessels for subsequent vasodilation curves because this dose provides a greater range over which relaxation could be assessed. Methacholine (muscarinic agonist; endothelial-dependent vasodilator) dose response curves (10 nmol/l -10 Amol/l) were performed alone or after a 20-min incubation with L-NAME alone, meclofenamate (MECLO) alone, L-NAME and MECLO together, or L-NAME, MECLO plus inhibitors of calcium-sensitive potassium channels (apamine, 10 Amol/l and charybdotoxin, 0.1 Amol/l).
In a separate set of experiments, methacholine curves were also assessed after a 1-h pre-incubation with the soluble polyethylene glycol -SOD (PEG -SOD; 50 units/ml) either alone or in combination L-NAME (20 min, 100 AM). Relaxation responses were also measured over a range of doses (1.0 nmol/l -10 Amol/l) to an exogenous nitric oxide donor, sodium nitroprusside (SNP), as well as a stable prostacyclin analogue, epoprostenol. All drugs, unless otherwise stated, were purchased from Sigma (St. Louis, MO).
Immunohistochemistry for peroxynitrite formation and vasoactive enzymes
At the time of dissection, mesenteric arteries that were not used for myograph experiments were fixed with 4% formaldehyde, and dehydrated overnight in 30% sucrose at 4 jC. Arteries were embedded in tissue freezing compound (O.C.T. Tissue Tekk, Fisher Scientific) and sectioned using a cryostat ( À 25 jC) at a thickness of 10 Am. The immunostaining protocol is described in brief. Slides were fixed with acetone, and blocked for 30 min at room temperature with 2% bovine serum albumin (BSA) in PBS (pH 7.4). Sections were then incubated with rabbit polyclonal anti-nitrotyrosine (1:100; Transduction Laboratories, San Diego, CA), prostacyclin synthase, PGHS-1 (1:200; Cayman Chemicals, Ann Arbor, MI) or eNOS (1:200; Santa Cruz, CA) overnight at 4 jC. The antirabbit secondary antibody, containing a rhodamine-TRITC fluorescent tag, was incubated for 40 min at room temperature. Sections were mounted with Vectashield H-1200 solution (containing DAPI, Burlingame, CA) and slides were sealed. For detection of nitrotyrosine fluorescence in mesenteric arteries, images were captured using an Olympus Microscope System (Model BX40) with Reflected Light Fluorescence Attachment (Model BX-FLA) and analyzed with Image Pro-Plus software (Media Cybernetics, Silver Spring, MD). Negative controls were performed by incubating slides either without primary or secondary antibody, or incubating with excess nitrotyrosine (10 AM in PBS, Sigma) before the addition of primary antibody [14] . All negative controls showed minimal immunofluorescence.
Data analysis and statistics
Dose response curves are graphically depicted as either percent relaxation or constriction and each point represents mean F standard error of the mean. EC 50 concentrations were calculated and compared between groups for the phenylephrine, SNP and epoprostenol responses using either a Student's t-test or a One Way Analysis of Variance (ANOVA), where appropriate. However, since methacholine-induced responses were non-sigmoidal in shape and because of the variability in the slopes of the curves, we were not able to use EC 50 doses for comparison. Thus, statistical significance between wild type and SOD À / À mice, as well as the effect of inhibitors for methacholine relaxation was determined using a Two-way ANOVA for repeated measures, followed by a Tukey post hoc test. Statistical significance was considered at P < 0.05. Immunofluorescence for nitrotyrosine was quantified using Sigma Scan 5.0 software, which measured mean optical intensity of the red fluorescence in mesen-teric vessels. These data were normalized for vessel size by dividing the optical intensity by area and data are expressed using this ratio. Statistical analysis was performed using a Student's t-test, P < 0.05. 
Results
Vascular reactivity to phenylephrine in SODÀ/À and wild type mesenteric arteries
There were no significant differences in overall sensitivity to phenylephrine between wild type and SOD À / À mice (EC 50 values: 4.53 F 0.45 Amol/l vs. 5.03 F 0.51 Amol/l; Fig. 1A) . Interestingly, the effect of PGHS inhibition on vasoconstriction was different between groups. In wild type mice, pre-incubation with MECLO (PGHS inhibitor) significantly enhanced the mesenteric sensitivity to phenylephrine, as indicated by a lower EC 50 concentration (EC 50 : 3.18 F 0.20 Amol/l vs. 4.53 F 0.45 Amol/l; P < 0.05; Fig.  1B ) suggesting modulation by a PGHS-dependent vasodilator. In contrast, MECLO had no effect on the phenylephrine dose response curve in SOD À / À mice (EC 50 : 4.48 F 0.41 Amol/l vs. 5.03 F 0.51 Amol/l; Fig. 1C ). There was a trend towards enhanced sensitivity to phenylephrine in wild type mice after L-NAME treatment; however, this effect did not reach statistical significance (EC 50 : 3.55 F 0.32 Amol/l vs. 4.53 F 0.45 Amol/l; P = 0.09; Fig.  1B ). Pre-incubation with the NOS inhibitor did not shift the constrictor response in SOD À / À mice (EC 50 : 4.85 F 0.32 Amol/l vs. 5.03 F 0.51 Amol/l; Fig. 1C ).
Endothelial-dependent relaxation in SODÀ/À and wild type mice; role of NOS and PGHS
Methacholine-induced relaxation was significantly impaired in SOD À / À mice compared to wild type mice ( Fig.  2A) . In wild type mice, methacholine relaxation was significantly blunted after incubation with either L-NAME or MECLO (Fig. 2B) . Conversely, in mesenteric arteries from SOD À / À mice, neither L-NAME nor MECLO had a significant effect on methacholine induced relaxation (Fig.  2C) . These data suggest that NOS and PGHS-mediated vasorelaxation in SOD À / À mice is compromised.
By incubating vessels with a combination of both L-NAME and MECLO, we assessed the remaining component of endothelial-dependent relaxation. In mesenteric Fig. 3 . Endothelial-dependent relaxation in mesenteric arteries from SOD À / À mice after 1-h incubation with PEG -SOD. Methacholineinduced relaxation in vessels from SOD À / À mice before PEG -SOD (.; n = 6), after PEG -SOD alone (o; n = 6) and after both PEG -SOD and L-NAME (n; 20 min, 100 AM; n = 5). Responses are expressed as percent relaxation and each value represents the mean F S.E.M. Different letters indicate statistically significant dose response curves at P < 0.05. arteries from both wild type and SOD À / À mice, blocking NOS and PGHS significantly reduced methacholine-induced relaxation ( Fig. 2B and C) . However, this residual relaxation was not statistically different between groups (maximum relaxation: 26 F 4.3% vs. 29 F 5.0%, P = 0.6). We also incubated mesenteric vessels from both wild type and SOD À / À mice with a combination of apamine and charybdotoxin (in the presence of L-NAME and MECLO) and these inhibitors completely blocked relaxation (data not shown), indicating that the remaining relaxation was indeed mediated by a factor(s) that acts on potassium channels (EDHF-like).
In order to determine whether the impaired endothelialdependent relaxation in SOD À / À mice was due to acute superoxide production leading to scavenging of nitric oxide, we treated mesenteric vessels with an exogenous cell permeable SOD (PEG -SOD) alone or in combination with L-NAME. Our data illustrate that pre-incubation with PEG -SOD was able to significantly enhance methacholine-induced relaxation in vessels from SOD À / À mice. Furthermore, administering L-NAME to vessels treated with PEG -SOD blunted the enhanced relaxation, such that the relaxation was not different from control curves (Fig. 3) . Interestingly, administering PEG -SOD to vessels from wild type mice caused a reduction in methacholine induced relaxation (maximum relaxation: 56.2 F 4.0% vs. 22.9 F3.2%; P < 0.05, data not shown). These data suggest that physiological, low levels of superoxide anion are important for mediating endothelial-dependent vascular functions [15 -17] .
Effect of exogenous nitric oxide and prostacyclin on mesenteric relaxation
Mesenteric arteries from wild type mice were significantly more sensitive to the nitric oxide donor, SNP, compared to arteries from SOD À / À mice (EC 50 : 0.24 F 0.03 Amol/l vs. 0.65 F 0.04 Amol/l; P < 0.05; Fig. 4A ). In order to determine whether this effect was specific to nitric oxide, we also used the prostacyclin agonist, epoprostenol. Our data show that the responses to the prostacyclin analogue were not significantly different between groups (EC 50 : 0.24 F 0.02 nmol/l vs. 0.27 F 0.06 nmol/l; Fig. 4B ), suggesting that nitric oxide specifically is being interfered with in SOD À / À mice.
Detection of peroxynitrite formation in SODÀ/À mice
Using fixed sections of mesenteric arteries, we performed immunohistochemistry for nitrotyrosine, which is a marker of peroxynitrite formation [18] . Our data illustrate that peroxynitrite formation was elevated in mesenteric vessels of SOD À / À mice (Fig. 5B ) when compared to wild type mice (Fig. 5A) . The mean intensity of immunofluorescence in wild type mice was 0.28 F 0.03 compared with 0.78 F 0.14 in vessels from SOD À / À mice ( P < 0.05; n = 5). In SOD À / À mice, nitrotyrosine immunostaining was evident mainly in the endothelium, but was also present in vascular smooth muscle. Incubation of sections without primary antibody result in a very low signal ( Fig. 5C) and was consistent for all other negative controls performed. Using immunohistochemistry, we also measured expression of the enzymes PGHS-1, prostacyclin synthase and eNOS in the mesenteric arteries from wild type and SOD À / À mice and no differences between groups were detected (data not shown).
Discussion
This study utilized the CuZn SOD knockout mouse to highlight mechanisms behind oxidant-induced vascular dysfunction. We demonstrated that in this model, in which peroxynitrite levels are elevated, vascular relaxation is significantly impaired, due to reduced PGHS and nitric oxide-dependent vasodilation. Furthermore, although we did not observe an overall difference in vasoconstrictor responses between the two groups, PGHS inhibition increased phenylephrine sensitivity only in wild type mice, which corroborates our conclusion that SOD À / À Fig. 5 . Immunohistochemistry for nitrotyrosine, a marker of peroxynitrite formation. Representative sections of mesenteric arteries from (A) wild type mice (n = 5) and (B) SOD À / À mice (n = 5) incubated overnight with rabbit polyclonal anti-nitrotyrosine antibody. Panel C is a negative control, which is a section incubated without primary antibody and panel D is the corresponding DAPI stained nuclei, in order to illustrate presence of the blood vessel. All images were taken at 100 Â magnification. mice have an impaired PGHS modulation of vascular reactivity, in addition to the reduced nitric oxide-dependent vasorelaxation.
Our hypothesis that oxidative stress is mediating the vascular dysfunction in SOD À / À mice is supported by evidence that after pre-incubation with PEG -SOD, methacholine-induced relaxation in SOD À / À mice was enhanced. The use of PEG -SOD to restore oxidant-induced vascular dysfunction has been used in a mouse model of diabetes, where it was also effective at reversing the deleterious effects of superoxide anion [19] . In our study, we speculate that the acute removal of superoxide anions reduces scavenging of nitric oxide, thus increasing its bioactivity as a vasodilator. Supporting this theory, relaxation in PEG -SOD-treated vessels was significantly reduced after incubation with L-NAME, whereas in untreated vessels from SOD À / À mice, L-NAME did not affect methacholine-induced relaxation. Thus, exogenous SOD enhanced NOS-mediated relaxation in knockout mice. However, it is likely that chronic elevated levels of pro-oxidants also alter enzymes important to vascular function (such as prostacyclin synthase and/or eNOS), hence acute PEG -SOD could not fully compensate for these changes. Indeed, relaxation in vessels from SOD À / À mice was only partially restored after PEG -SOD treatment and did not vasodilate to the levels observed in wild type mice.
Our data illustrates highly impaired endothelial-dependent relaxation, and is in agreement with a recent study that observed a significantly reduced response to a bolus administration of acetylcholine in the carotid artery of CuZn SOD À / À mice [20] . Further, in other animal models of oxidative stress (glutathione peroxidase gene (GPx-1) knockout mouse and apolipoprotein E knockout mouse) endothelial-dependent relaxation was found to be impaired, which also supports the findings of the current study [21, 22] . However, the contribution of PGHS and nitric oxide in modulating the vascular reactivity was not demonstrated in these studies.
Our results illustrate that PGHS-mediated relaxation is compromised in mesenteric vessels from SOD À / À mice and thus, is partially responsible for the altered vascular reactivity. We speculate that the mechanism behind this reduced PGHS-mediated dilation is a decrease in prostacyclin (the predominant vasodilator produced by PGHS in mesenteric arteries) [23] . In the current study, we observed no difference in relaxation responses to exogenous prostacyclin, supporting the conclusion that production of a PGHS-dependent vasodilator is indeed reduced in SOD À / À mice, rather than the vessels being less sensitive to prostacyclin. In vessels from SOD À / À mice, we found increased evidence of nitrotyrosine, a marker of peroxynitrite. Evidence suggests that this reactive nitrogen species can alter the production of prostacyclin through a variety of mechanisms. For example, our laboratory found that peroxynitrite reduces protein levels of prostacyclin synthase in endothelial cells [5] . Additionally, Zou et al. [24, 25] have extensively described how peroxynitrite inhibits the activity of prostacyclin synthase through a tyrosine nitrosylation-dependent reaction. In mesenteric arteries from SOD À / À mice, we did not detect reduced levels of prostacyclin synthase, suggesting that in this model, inhibition of prostacyclin synthase activity by peroxynitrite may be responsible for the reduced PGHSdependent vasodilation.
Nitric oxide mediated vasodilation is also compromised in SOD À / À mice, as evidenced by reduced NOS-dependent endothelial-mediated relaxation and reduced sensitivity to the nitric oxide donor sodium nitroprusside. It is possible that nitric oxide is simply unavailable since it is being scavenged, forming peroxynitrite. However, reactive nitrogen species can also alter other aspects of the NOS pathway. For example, peroxynitrite can decrease the activity of eNOS via either directly uncoupling (oxidation) the zinc cluster of eNOS [26] or by the destabilization of tetrahydrobiopterin, an important co-factor for NOS activity [27] . These effects on eNOS activity may be involved in the impaired endothelial-dependent relaxation in mesenteric arteries from SOD À / À mice, since eNOS protein levels were not different between SOD À / À and wild type mice. Our conclusion is in agreement with other mouse models in which NOS-dependent relaxation was impaired [28] . Therefore, the mechanism(s) by which reactive nitrogen species impair vascular function are likely complex, affecting many different pathways involved in vascular relaxation.
EDHF-mediated relaxation has been described as endothelial-dependent relaxation that is not inhibited by NOS and PGHS antagonists, but is inhibited by potassium channel blockers [29] . In the SOD À / À mice, the magnitude of relaxation that is dependent on an EDHF-like factor was not different from arteries from wild type mice. This is in contrast to other models of vascular dysfunction, in which it is suggested that an EDHF-like factor is compensating, including in vessels from eNOS knockout mice [30] , women with preeclampsia [31] and hypercholesterolemic rabbits [32] .
In conclusion, our data illustrate that CuZn SOD knockout mice have reduced NOS and PGHS-dependent modulation of vascular reactivity. These abnormalities may be due to increased peroxynitrite-induced endothelial cell dysfunction, which is also indicative of a reduced capacity of nitric oxide to induced vasodilation. The findings of this study are relevant to clinical conditions of vascular dysfunction, because reduced SOD expression and activity (and increased peroxynitrite formation) are associated with preeclampsia [33, 34] , aging [35, 36] , atherosclerosis [37, 38] and diabetes [39, 40] . Using the CuZn SOD knockout mouse as a tool to better understand the mechanisms of oxidant-induced endothelial cell dysfunction provides new opportunities to investigate novel therapeutic targets for the treatment and prevention of vascular disease.
